Baba Ramdev begs Uttarakhand Officer to spare him as Supreme Court slams Patanjali misleading ads admin, April 10, 2024 The Supreme Court recently rejected Patanjali’s apology affidavits in a controversy involving the company’s misleading advertisements. The court was dissatisfied with what it perceived as insincere apologies from the company and its founders. During the proceedings, the court focused on Dr. Mithilesh Kumar, the Joint Director of the state’s Food and Drug Administration, who pleaded for mercy. Despite Dr. Kumar’s plea, the court did not relent and questioned the actions taken by the Uttarakhand FDA in response to the misleading advertisements. The court raised concerns about the FDA’s actions, pointing out that warning Patanjali was not sufficient under the Drugs and Magic Remedies (Objectionable Advertisements) Act. The court also criticized the FDA for its inaction and lack of reports regarding the misleading advertisements and emphasized the seriousness of the public health implications. The court’s criticism extended to the AYUSH Ministry, questioning why it had not taken action against Patanjali for its misleading ads. This came in the context of a contempt case against Patanjali for continuing to publish advertisements with false claims despite being directed by the court to stop doing so. Overall, the court’s strong stance against both Patanjali and the authorities responsible for regulating such advertisements reflects its commitment to upholding public health and addressing deceptive marketing practices. Patanjali